Delivery Order SPE2DB22D2007-SPE2DB25FJ4PZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,875.58 to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be fulfilled from the vendor's operations in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a $10,547.87 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count). This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, due for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $39,507.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units), with an ultimate completion date of September 2, 2025. This non-set-aside competitive award was issued on August 29, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. Trelegy Ellipta is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease and...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.27 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination respiratory medication used to treat chronic obstructive...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,832.12 on August 28, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination inhaler used for maintenance...
- The Defense Logistics Agency awarded a $5,007.60 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The point of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $16,076.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $11,129.60 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on September 4, 2025, with completion scheduled for September 5, 2025. This firm fixed price delivery order was issued without a set-aside designation and reflects a competitively awarded transaction. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Trelegy Ellipta is a...
- The Defense Logistics Agency awarded a delivery order valued at $28,745.16 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's facility in Conshohocken, Pennsylvania. The product is a combination respiratory medication used in the treatment of chronic...
- The Defense Logistics Agency awarded a $12,545.94 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 inhalers (60-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4PZDelivery Order
The Defense Logistics Agency awarded a $6,017.40 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This firm fixed-price, non-set-aside contract is categorized as a delivery order under a larger indefinite delivery vehicle and will be performed at the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of September 4, 2025. Trelegy Ellipta is a combination respiratory medication used in the treatment of chronic obstructive pulmonary disease and asthma, reflecting the Defense Logistics Agency Medical Supply Chain's ongoing procurement of pharmaceutical products to support military healthcare programs. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides global pharmaceutical support to military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor supplying an extensive range of medications, vaccines, medical devices, and healthcare commodities through competitively awarded contracts with the Defense Logistics Agency. The company's federal contract portfolio demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains for military and veteran healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 9/3/25 |